- In February 2024, Johnson & Johnson (US) received CE mark approval for the VARIPULSE Pulse Field Ablation Platform, designed to enhance workflow and provide real-time visualization
- In December 2023, Medtronic announced FDA approval for its PulseSelect Pulsed Field Ablation (PFA) System, developed to treat paroxysmal and persistent atrial fibrillation (AF) with advanced safety features, efficient pulmonary vein isolation (PVI), and precise catheter maneuverability
- In May 2023, Abbott received FDA approval for its TactiFlex Ablation Catheter, Sensor Enabled, the first catheter with a flexible tip and contact force technology. The device is used for atrial fibrillation (AFib) ablation, offering shorter procedure times and improved safety
- In October 2022, PENTAX Medical launched the C2 CryoBalloon Ablation System in Canada to address Barrett's Esophagus treatment needs effectively
- In March 2022, Quantum Surgical secured 510(k) clearance from the FDA for its Epione robot, a system capable of planning, targeting, delivering, and confirming tumor ablation for cancer treatment
